Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The STAT family: Key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment
Mengxuan Zhu, Suyao Li, Xin Cao, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 18-31
Closed Access | Times Cited: 17

Showing 17 citing articles:

SIRPB1 regulates inflammatory factor expression in the glioma microenvironment via SYK: functional and bioinformatics insights
Ren Geng, Yao Zhao, Wanzhen Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Periplogenin inhibits pathologic synovial proliferation and infiltration in rheumatoid arthritis by regulating the JAK2/3-STAT3 pathway
Xiaoqin Zhong, Wei Feng, Lianjie Liu, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111487-111487
Closed Access | Times Cited: 3
Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
Xiao-Hai Song, Lan Yang, Xiuli Zheng, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 10
Targeting tumorous Circ-E-Cadherinencoded C-E-Cad inhibits the recruitment and function of breast cancer-associated myeloid-derived suppressor cells
Junyi Zhou, Hao Xu, X Li, et al.
Pharmacological Research (2024) Vol. 204, pp. 107204-107204
Open Access | Times Cited: 2
Transcriptional regulation of cancer stem cell: regulatory factors elucidation and cancer treatment strategies
Zhengyue Zhang, Yanjie Zhang
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Deciphering Regulatory T-Cell Dynamics in Cancer Immunotherapy: Mechanisms, Implications, and Therapeutic Innovations
Sankha Bhattacharya, Gaurav Paraskar, Megha Jha, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2215-2236
Closed Access | Times Cited: 1
Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types
Andreas Andrianto, I Ketut Sudiana, Desak Gede Agung Suprabawati, et al.
F1000Research (2023) Vol. 12, pp. 841-841
Open Access | Times Cited: 4
RXR signaling targeted cancer therapy
Wenrui Zhao, Suyao Li, Ruoxue Chen, et al.
The Innovation Life (2023) Vol. 1, Iss. 1, pp. 100014-100014
Open Access | Times Cited: 3
Oral membrane-biomimetic nanoparticles for enhanced endocytosis and regulation of tumor-associated macrophage
Xiaoyan Gu, Rongguang Zhang, Yingwei Sun, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Deep dissection of stemness-related hierarchies in hepatocellular carcinoma
Rui Liang, Weifeng Hong, Yang Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Unveiling the STAT3-ACC1 axis: a key driver of lipid metabolism and tumor progression in non-small cell lung cancer
Zhai Hong, Tiansheng Zheng, Lihong Fan
Journal of Cancer (2024) Vol. 15, Iss. 8, pp. 2340-2353
Open Access
TFAP2A drives non-small cell lung cancer (NSCLC) progression and resistance to targeted therapy by facilitating the ESR2-mediated MAPK pathway
Dingguo Wang, Jian Gao, Jing Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
Special issue: Deregulated transcription factors in the cancer therapeutic challenges: An update on cancer stemness features
Abdul Quaiyoom Khan
Seminars in Cancer Biology (2023) Vol. 96, pp. 3-4
Closed Access | Times Cited: 1
Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma
Jian‐Feng Xiang, Wangrui Liu, Shifan Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 16015-16030
Closed Access | Times Cited: 1
Targeting cancer stem cell plasticity in triple-negative breast cancer
Zhengwang Guo, Shuyan Han
Exploration of Targeted Anti-tumor Therapy (2023) Vol. 4, Iss. 6, pp. 1165-1181
Open Access | Times Cited: 1
Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types
Andreas Andrianto, I Ketut Sudiana, Desak Gede Agung Suprabawati, et al.
F1000Research (2023) Vol. 12, pp. 841-841
Open Access
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient
Shubing Zhang, Jinhua Yan, Lan He, et al.
Cancer Gene Therapy (2023) Vol. 31, Iss. 3, pp. 484-494
Closed Access
Page 1

Scroll to top